# CYLTEZO
> **BLA761058** · Biologics License Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2017-08-25
## Drug
- **FDA Application Number:** BLA761058
- **Application type:** Biologics License Application
- **Brand name:** CYLTEZO
- **Generic name:** ADALIMUMAB-ADBM
- **Active ingredients:** ADALIMUMAB-ADBM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BOEHRINGER INGELHEIM
- **Manufacturer:** QUALLENT PHARMACEUTICALS HEALTH LLC
- **First approval:** 2017-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761058)
---
*AI Analytics · CC0 1.0*